# The Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3)

> **NCT00423176** · PHASE3 · TERMINATED · sponsor: **Organon and Co** · enrollment: 237 (actual)

## Conditions studied

- Sinusitis

## Interventions

- **DRUG:** MFNS and antibiotic
- **DRUG:** Matching Placebo nasal spray plus antibiotic

## Key facts

- **NCT ID:** NCT00423176
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 237 (ACTUAL)
- **Why stopped:** Based on business priorities. Not related to any safety or efficacy issue \& took place before data were unblinded or analyzed
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00423176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00423176, "The Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00423176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*